Background
Disease burden
Lifestyle interventions
Preferences
Preference elicitation
Preference studies
Study objective and rationale
Methods
Protocol
Eligibility criteria
Criteria | Inclusion | Exclusion |
---|---|---|
Population | • Patients | • Patients suffering from other conditions than diabetes • Professionals (physicians, nurses, etc.) |
Condition | • T1DM and T2DM • All stages of diabetes disease • Complications of diabetes • Metabolic disorders in relation with diabetes | • Conditions unrelated to diabetes |
Intervention | • Quantitative elicitation of preferences for lifestyle interventions • All available quantitative methods for stated preferences (MCDA, MADM, MODM, CA, DCE, AHP, BWS, WTP, etc.) | • Qualitative elicitation of preferences for lifestyle interventions • Quantitative or qualitative elicitation of preferences exclusively for pharmacological treatment of diabetes • Elicitation of utilities |
Study design | • The study is based on single and/or multiple data sets | |
Type of publication | • Publications in peer-reviewed journals which can be retrieved through our search approach • Studies, to which full publication is available | • Editorials, comments, newspaper articles, and other forms of popular media • Conference abstracts • Studies, to which no full publication is available |
Date | • No restriction | |
Language | • No restrictions on language, but available English, French, Spanish, or German abstract is a pre-condition for inclusion | • No English, French, Spanish, or German abstract available |
Information sources
Search strategy
Databank | PubMed (NLM) | |
Timespan: | Unlimited | |
Language: | Unrestricted | |
Date of creation: | 09 September 2017 | |
# | Hits | Query |
#1 | 64,223 | “DIABETES MELLITUS, TYPE 1”[MESH] |
#2 | 95,093 | “DIABETES MELLITUS, TYPE 2”[MESH] |
#3 | 7315 | “DIABETES INSIPIDUS”[MESH] |
#4 | 34,268 | “INSULIN/ADMINISTRATION AND DOSAGE”[MESH] OR “INSULIN/ECONOMICS”[MESH] OR “INSULIN/ORGANIZATION AND ADMINISTRATION”[MESH] OR “INSULIN/THERAPEUTIC USE”[MESH] OR “INSULIN/THERAPY”[MESH] |
#5 | 256,585 | (diabetes [ti] OR diabetic [ti] OR T1DM [ti] OR T2DM [ti] OR NIDDM [ti]) |
#6 | 311,637 | #1 OR #2 OR #3 OR #4 OR #5 |
#7 | 8688 | “RISK REDUCTION BEHAVIOR”[MESH] |
#8 | 69,754 | “LIFE STYLE”[MESH] |
#9 | 134,304 | “EXERCISE”[MESH] |
#10 | 96,110 | “SPORTS”[MAJR] |
#11 | 17,011 | “REHABILITATION”[MESH:NOEXP] |
#12 | 4582 | “COMMUNITY HEALTH PLANNING”[MESH] |
#13 | 142,616 | “HEALTH EDUCATION”[MESH] |
#14 | 59,790 | “HEALTH PROMOTION”[MESH] |
#15 | 499 | change*[ti] AND diabetes[tiab] AND (diet[ti] OR behavior*[ti] OR behaviour*[ti] OR nutrition [ti] OR activity [ti] OR activities [ti] OR training [ti] OR physical [ti] OR athletic [ti]) |
#16 | 1,191,618 | (lifestyle [tiab] OR life style [tiab] OR behaviour*[ti] OR diet program*[tiab] OR behavior*[ti] OR exercise [ti] OR training program*[tiab] OR preventive strategy [tiab] OR prevention program*[tiab] OR behavioral prevention [tiab] OR behavioral program*[tiab] OR way of life [tiab] OR manner of living [tiab] OR behavioral intervention*[tiab] OR diet [ti] OR behavioral intervention*[tiab] OR community program*[tiab] OR nutrition [ti] OR activity [ti] OR activities [ti] OR training [ti] OR physical [ti] OR athletic [ti]) |
#17 | 2,779,775 | #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR 13 OR #14 OR #16 |
#18 | 47,980 | #6 AND #17 |
#19 | 48,163 | #15 OR #18 |
#20 | 17 | #19 AND (conjoint [tiab] OR discrete choice [tiab] OR multi-criteria*[tiab] OR multicriteria*[tiab] OR multi-attribute*[tiab] OR multiattribute*[tiab] OR multi-objective*[tiab] OR multiobjective*[tiab] OR multi-alternative*[tiab] OR multialternative*[tiab] OR multiple criteria[tiab] OR multiple attribute*[tiab] OR multiple objective*[tiab] OR multiple alternative*[tiab]) |
#21 | 24 | #19 AND (stated preference*[tiab] OR willingness to pay [tiab] OR willing to pay [tiab] OR wtp [tiab] OR analytic hierarchy process*[tiab] OR ahp [tiab]) |
#22 | 218 | #19 AND (decision-analy*[tiab] OR decision-making [tiab] OR patient preference*[tiab] OR patient* prioriti*[tiab] OR (patient [ti] AND prioritizing[ti]) OR elicit* patient*[tiab] OR preference*[ti] OR health-state utilit*[tiab] OR EQ-5D*[ti]) |
#23 | 15 | #19 AND (health state utilit* OR utility measure*[tiab] OR health state utilit*[tiab] OR utility value*[tiab] OR utility score*[tiab] OR utility-based score*[tiab] OR health state valuation [tiab] OR m-mauf*[tiab]) |
#24 | 19 | #19 AND (hui2 [tiab] OR hui3 [tiab] OR hui-2 [tiab] OR hui-3 [tiab] OR health utility [tiab] OR health utilities [tiab]) |
#25 | 0 | #19 AND (part-worth [tiab] OR paired comparisons [tiab] OR pairwise choices [tiab] OR pairwise choice [tiab]) |
#26 | 97 | #19 AND (decision-analy*[ti] OR decision-making [ti] OR decision support*[ti] OR preference*[ti] OR prioriti*[ti] OR ((choice*[ti] OR elicit*[ti]) AND patient*[ti])) |
27 | 15 | #19 AND (best-worse scaling [ti] OR preference weight [ti] OR willingness to accept [ti] OR out-of-pocket[ti] OR mcda [ti] OR trade-off[ti] OR utilities [ti] OR valuation [ti]) |
28 | 2 | #19 AND (goal programming OR vector optimization [tiab] OR value theory [tiab] OR maut [tiab] OR mavt [tiab] OR promethee [tiab] OR preference ranking organization [tiab] OR method for enrichment evaluations [tiab] OR electre [tiab] OR elimination et choix traduisant la realite [tiab]) |
#29 | 0 | #19 AND (mental modeling [tiab] OR trade-off analysis [tiab] OR tradeoff analysis [tiab] OR risk-based prioritization [tiab]) |
#30 | 0 | #19 AND (((gaia[tiab] OR meteor [tiab] OR kepner-tregoe [tiab] OR archimedean [tiab] OR tchebycheff [tiab] OR min-max [tiab] OR step method [tiab] OR interactive multiple goal programming [tiab] OR imgp [tiab] OR priam [tiab] OR scalarizing function [tiab] OR outranking concept [tiab] OR goal point approach*[tiab] OR reference point approach*[tiab] OR concordance index [tiab] OR concordance indices[tiab] OR discordance indices [tiab] OR discordance index [tiab] OR trade-off term*[tiab] OR trade-off terms [tiab] OR voting weight*[tiab] OR fuzzy set theory [tiab] OR fuzzy sets [tiab] OR correspondence analysis [tiab]) AND (decision-making [tiab] OR decision-analy*[tiab])) |
#31 | 1 | 25,151,503 [pmid] |
#32 | 103 | Similar articles for PubMed (Select 25,151,503) |
#33 | 1 | 25,348,049 [pmid] |
#34 | 103 | Similar articles for PubMed (Select 25,348,049) |
#35 | 57 | #34 AND (diabetes OR diabetic OR insulin*) |
#36 | 1 | 24,289,831 [pmid] |
#37 | 188 | Similar articles for PubMed (Select 24,289,831) |
#38 | 55 | #37 AND (diabetes OR diabetic OR insulin*) |
#39 | 199 | #32 OR #35 OR #38 |
#40 | 509 | #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #32 OR #35 OR #38 |